Page last updated: 2024-08-21

pyrazines and Sarcoma 180

pyrazines has been researched along with Sarcoma 180 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, Y; Guo, J; Lei, H; Li, Q; Pang, D; Wang, P; Xu, K; Zhang, H; Zhang, Y	1

Other Studies

1 other study(ies) available for pyrazines and Sarcoma 180

Article	Year
A new ligustrazine derivative--pharmacokinetic evaluation and antitumor activity by suppression of NF-kappaB/p65 and COX-2 expression in S180 mice. Die Pharmazie, 2013, Volume: 68, Issue:9 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Calibration; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Data Interpretation, Statistical; Drug Stability; Female; Immunohistochemistry; Limit of Detection; Male; Mice; Pyrazines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sarcoma 180; Spectrophotometry, Ultraviolet; Transcription Factor RelA	2013

Article

Year

A new ligustrazine derivative--pharmacokinetic evaluation and antitumor activity by suppression of NF-kappaB/p65 and COX-2 expression in S180 mice.

Die Pharmazie, 2013, Volume: 68, Issue:9

Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Calibration; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Data Interpretation, Statistical; Drug Stability; Female; Immunohistochemistry; Limit of Detection; Male; Mice; Pyrazines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sarcoma 180; Spectrophotometry, Ultraviolet; Transcription Factor RelA

2013